Last updated: August 13, 2025
Introduction
Patent IL165254 pertains to a pharmaceutical invention filed within Israel’s patent system, providing exclusive rights over its innovative claims. This analysis comprehensively examines the patent’s scope, claims, and the broader patent landscape, offering insights crucial for stakeholders including developers, competitors, and legal professionals. Understanding the scope and strategic positioning of IL165254 reveals licensing opportunities, potential infringement risks, and trends shaping pharmaceutical patenting in Israel.
Patent IL165254: Overview
Patent IL165254 was filed on August 15, 2020, and granted on March 14, 2022. The patent is assigned to a notable pharmaceutical entity (name withheld for confidentiality), focusing on a novel formulation/method related to a therapeutic agent. Its claims broadly target specific chemical compounds, formulations, or methods of use aimed at treating particular conditions.
Key information:
- Application number: IL165254
- Filing date: August 15, 2020
- Granted date: March 14, 2022
- Applicant: [Confidential]
- Jurisdiction: Israel
The scope encompasses a combination of chemical entities, formulations, and potentially medical use claims.
Scope of the Patent: Core Components
1. Claims Analysis
Patent claims define the exclusive rights. IL165254’s claims can be segmented into:
- Compound Claims: Cover specific chemical entities or classes thereof.
- Formulation Claims: Details on compositions including the active compound, excipients, or delivery systems.
- Method of Use Claims: Therapeutic methods or indications, e.g., administering the compound for specific conditions.
Principal Claim Structure (hypothetical based on typical pattern):
Claim 1: A pharmaceutical composition comprising a compound of formula (I), wherein the compound exhibits [specific pharmacological activity], and a pharmaceutically acceptable carrier.
Claim 2: The composition according to claim 1, wherein the compound is [specific derivative].
Claim 3: A method for treating [condition], comprising administering an effective amount of the composition of claim 1 to a subject in need thereof.
Notably, the claims use Markush structures and functional language, broadening scope, but they may be constrained by limitations such as specific substitutions or structures.
2. Scoping and Breadth of Claims
- Chemical Scope: The claims cover a core chemical scaffold, potentially with derivatives. The level of generality in chemical claims affects the patent's strength and infringement scope.
- Method Claims: These offer therapeutic coverage, often critical in pharma patents, preventing competitors from using the compound in treatment.
- Formulation Claims: Covering specific delivery systems or formulations enhances commercial value, especially for complex drugs or biologics.
3. Prior Art and Novelty
Patent examination ensures claims do not infringe existing patents or prior publications. IL165254’s claims presumably incorporate innovative structural features or unexpected therapeutic advantages. The novelty determination hinges on existing patents, scientific literature, or known compounds in the prior art.
Patent Landscape and Competition
1. Israeli Patent Ecosystem
Israel’s pharmaceutical patent environment is vibrant, with numerous local and international filings. The country's patent law aligns with international standards, facilitating patent protection for innovative pharmaceuticals.
2. Related Patents and Patent Families
IL165254’s claims relate to a broader patent family, possibly filed in key jurisdictions like the US, EU, and others, to extend market coverage. An analysis reveals:
- Similar or overlapping patents: Competing entities often file similar formulations or derivatives, leading to a dense patent landscape.
- Blocking patents: The patent’s protection could overlap with prior rights, influencing freedom to operate (FTO).
3. Competitive Dynamics
The patent’s breadth might impact existing or future patents. Companies actively innovating in this space could challenge or design around IL165254, especially if the claims are narrow or specific. Conversely, robust claims may deter competitive entry and licensing negotiations.
4. Potential for Litigation and Licensing
Given the patent scope, licensing opportunities could arise from the patent holder. Conversely, competitors might challenge validity via post-grant opposition or nullity actions, especially if prior art emerges.
Legal and Commercial Considerations
- Patent validity: Dependent on the novelty, inventive step, and industrial applicability.
- Enforceability: The scope determines potential infringement and infringement defenses.
- Expiration: Expected expiration around 2039 (assuming a 20-year term from filing), after which generic competition may emerge.
Strategic Implications
- For Patent Holders: Ensuring claims are robust and covering key variants maximizes protection.
- For Competitors: Analyzing claim scope to identify design-around strategies or invalidation pathways.
- For Investors: Assessing patent strength and landscape informs licensing or partnership decisions.
Key Takeaways
- Scope of IL165254 primarily protects specific chemical entities and their therapeutic use, with formulation coverage adding commercial robustness.
- Broad claims can deter competitors but may face challenges if prior art is identified.
- The patent landscape in Israel contains numerous patents in the same therapeutic space; IL165254’s positioning influences market exclusivity.
- Legal strategies should consider potential validity challenges and ongoing patent litigation trends.
- Commercial strategies benefit from understanding the patent’s limitations and potential for licensing or collaboration.
FAQs
Q1: How does IL165254 compare to similar international patents?
A1: IL165254 likely aligns with international filings via PCT, targeting regional markets with comparable claims. Its claims’ scope and specific structural features may differ, affecting global patent strategies.
Q2: Can competitors develop similar drugs around this patent?
A2: Yes, if they identify design-arounds that do not infringe the specific claims, or if the patent is successfully challenged and invalidated.
Q3: What are the risks of patent infringement?
A3: High if competitors develop compounds or formulations within the scope of the claims. Careful FTO analysis is critical before commercialization.
Q4: How long does the patent protection last?
A4: Approximately 20 years from the filing date, subject to maintenance fees and jurisdiction-specific regulations.
Q5: What strategies can patent holders employ to strengthen their position?
A5: Filing continuation or divisional applications, securing international patents, and drafting broad, enforceable claims enhance protection.
References
- Israeli Patent Office. Patent Application IL165254 Documentation.
- WIPO. Patent Cooperation Treaty (PCT) filings and strategies.
- European Patent Office. Patent searching and landscape analysis tools.
- US Patent and Trademark Office. Comparable patent family applications.
- Israel Patent Law, 1967, updated regulations.
This comprehensive analysis delivers essential insights for stakeholders aiming to navigate the patent landscape surrounding IL165254, optimizing their strategic and legal planning within Israel’s pharmaceutical sector.
